• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

降压治疗起始对健康相关生活质量和心血管风险因素水平的影响:一项前瞻性、干预性研究。

The impact of antihypertensive treatment initiation on health-related quality of life and cardiovascular risk factor levels: a prospective, interventional study.

机构信息

University of Eastern Finland, Kuopio, Finland.

University of Turku, Turku, Finland.

出版信息

BMC Cardiovasc Disord. 2021 Sep 16;21(1):444. doi: 10.1186/s12872-021-02252-7.

DOI:10.1186/s12872-021-02252-7
PMID:34530733
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8447729/
Abstract

BACKGROUND

Effective prevention and treatment of hypertension is one of the most potential interventions in terms of preventing cardiovascular deaths and disabilities. However, the treatment control is often poor. This may be partly explained by the impact of hypertension diagnoses and treatment on health-related quality of life. Quality of life is also an important outcome for a hypertensive patient. Most of the previous studies on health-related quality of life in hypertension have concentrated on patients with treated hypertension and less is known about the initiation of medication and the first treatment year.

METHODS

In this interventional study, we followed 111 primary care patients with newly diagnosed hypertension in real world primary care setting in Finland for 12 months.

RESULTS

We found significant decrease in both systolic and diastolic blood pressure levels, as well as modest decrease in cholesterol levels and alcohol consumption. However, the health-related quality of life also slightly deteriorated during the first treatment year.

CONCLUSIONS

Our study shows that the initiation of hypertension treatment results in cardiovascular risk decrease among newly diagnosed Finnish hypertensive patients, but it is accompanied by small negative impact on health-related quality of life. However, the deterioration in health-related quality of life is of small magnitude and earlier research demonstrates several measures to enhance treatment and avoid impairment in health-related quality of life. Trial registration ClinicalTrials NCT02377960 (Date of registration: 04/03/2015).

摘要

背景

有效预防和治疗高血压是预防心血管疾病死亡和残疾的最有潜力的干预措施之一。然而,治疗控制往往很差。这可能部分解释了高血压诊断和治疗对健康相关生活质量的影响。生活质量也是高血压患者的一个重要结果。以前关于高血压患者健康相关生活质量的大多数研究都集中在接受治疗的高血压患者上,而对药物治疗的开始和第一年治疗知之甚少。

方法

在这项干预性研究中,我们在芬兰的真实初级保健环境中对 111 名新诊断的高血压初级保健患者进行了为期 12 个月的随访。

结果

我们发现收缩压和舒张压水平均显著下降,胆固醇水平和饮酒量也适度下降。然而,在第一年的治疗中,健康相关的生活质量也略有恶化。

结论

我们的研究表明,高血压治疗的开始会降低新诊断的芬兰高血压患者的心血管风险,但同时也对健康相关的生活质量产生微小的负面影响。然而,健康相关生活质量的恶化程度很小,早期研究表明有几种措施可以提高治疗效果,避免健康相关生活质量受损。试验注册 ClinicalTrials NCT02377960(注册日期:2015 年 3 月 4 日)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1ad/8447729/5625c12c2293/12872_2021_2252_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1ad/8447729/cbf9cc77b1d9/12872_2021_2252_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1ad/8447729/5625c12c2293/12872_2021_2252_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1ad/8447729/cbf9cc77b1d9/12872_2021_2252_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1ad/8447729/5625c12c2293/12872_2021_2252_Fig2_HTML.jpg

相似文献

1
The impact of antihypertensive treatment initiation on health-related quality of life and cardiovascular risk factor levels: a prospective, interventional study.降压治疗起始对健康相关生活质量和心血管风险因素水平的影响:一项前瞻性、干预性研究。
BMC Cardiovasc Disord. 2021 Sep 16;21(1):444. doi: 10.1186/s12872-021-02252-7.
2
Feasibility of a checklist in treating hypertension in primary care - base line results from a cluster-randomised controlled trial (check and support).基层医疗中高血压治疗检查表的可行性:一项群组随机对照试验(check and support)的基线结果。
BMC Cardiovasc Disord. 2018 Dec 19;18(1):240. doi: 10.1186/s12872-018-0963-5.
3
The (cost-)effectiveness of a patient-tailored intervention programme to enhance adherence to antihypertensive medication in community pharmacies: study protocol of a randomised controlled trial.一项针对社区药房患者定制干预方案以提高抗高血压药物依从性的(成本-)效益分析:一项随机对照试验的研究方案
Trials. 2017 Jan 19;18(1):29. doi: 10.1186/s13063-016-1696-3.
4
Lifestyle Changes in Relation to Initiation of Antihypertensive and Lipid-Lowering Medication: A Cohort Study.生活方式改变与抗高血压和降脂药物的起始使用:一项队列研究。
J Am Heart Assoc. 2020 Feb 18;9(4):e014168. doi: 10.1161/JAHA.119.014168. Epub 2020 Feb 5.
5
HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.土耳其的HYT高血压:关于单独使用钙通道阻滞剂或与其他抗高血压药物联合使用时血压控制情况的横断面调查
High Blood Press Cardiovasc Prev. 2015 Jun;22(2):165-72. doi: 10.1007/s40292-015-0091-6. Epub 2015 Apr 22.
6
The Role of Beta-Blockers in the Treatment of Hypertension.β受体阻滞剂在高血压治疗中的作用
Adv Exp Med Biol. 2017;956:149-166. doi: 10.1007/5584_2016_36.
7
Personalized text message and checklist support for initiation of antihypertensive medication: the cluster randomized, controlled check and support trial.个性化短信和清单支持启动降压药物治疗:集群随机对照检查和支持试验。
Scand J Prim Health Care. 2020 Jun;38(2):201-209. doi: 10.1080/02813432.2020.1753380. Epub 2020 May 2.
8
Adding a low-dose antihypertensive regimen would substantially improve the control of hypertension and reduce cardiovascular morbidity among uncomplicated hypertensive patients.在未合并其他疾病的高血压患者中,添加一种低剂量降压方案可显著改善高血压的控制,并降低心血管发病率。
Eur J Prev Cardiol. 2012 Aug;19(4):712-22. doi: 10.1177/1741826711410835. Epub 2011 May 24.
9
Real-life appraisal on blood pressure targets achievement in adult outpatients at high cardiovascular risk.成人心血管高危门诊患者血压目标达标真实世界评价。
Nutr Metab Cardiovasc Dis. 2021 Feb 8;31(2):472-480. doi: 10.1016/j.numecd.2020.10.015. Epub 2020 Oct 24.
10
The COSEHC™ Global Vascular Risk Management quality improvement program: first follow-up report.COSEHC™全球血管风险管理质量改进项目:首次随访报告。
Vasc Health Risk Manag. 2013;9:391-400. doi: 10.2147/VHRM.S44950. Epub 2013 Jul 22.

本文引用的文献

1
Personalized text message and checklist support for initiation of antihypertensive medication: the cluster randomized, controlled check and support trial.个性化短信和清单支持启动降压药物治疗:集群随机对照检查和支持试验。
Scand J Prim Health Care. 2020 Jun;38(2):201-209. doi: 10.1080/02813432.2020.1753380. Epub 2020 May 2.
2
Health-related quality of life in blood pressure control and blood lipid-lowering therapies: results from the CHIEF randomized controlled trial.血压控制和降脂治疗与健康相关的生活质量:来自 CHIEF 随机对照试验的结果。
Hypertens Res. 2019 Oct;42(10):1561-1571. doi: 10.1038/s41440-019-0281-z. Epub 2019 Jun 13.
3
Feasibility of a checklist in treating hypertension in primary care - base line results from a cluster-randomised controlled trial (check and support).
基层医疗中高血压治疗检查表的可行性:一项群组随机对照试验(check and support)的基线结果。
BMC Cardiovasc Disord. 2018 Dec 19;18(1):240. doi: 10.1186/s12872-018-0963-5.
4
Physical activity, cardiovascular health, quality of life and blood pressure control in hypertensive subjects: randomized clinical trial.体力活动、心血管健康、生活质量和高血压患者的血压控制:随机临床试验。
Health Qual Life Outcomes. 2018 Sep 14;16(1):184. doi: 10.1186/s12955-018-1008-6.
5
2018 ESC/ESH Guidelines for the management of arterial hypertension.2018年欧洲心脏病学会/欧洲高血压学会动脉高血压管理指南。
Eur Heart J. 2018 Sep 1;39(33):3021-3104. doi: 10.1093/eurheartj/ehy339.
6
The quality of life in Chinese population with chronic non-communicable diseases according to EQ-5D-3L: a systematic review.基于 EQ-5D-3L 评估中国慢性非传染性疾病患者生命质量的系统评价。
Qual Life Res. 2018 Nov;27(11):2799-2814. doi: 10.1007/s11136-018-1928-y. Epub 2018 Jul 6.
7
Quality of Life and Its Association With Treatment Satisfaction, Adherence to Medication, and Trust in Physician Among Patients With Hypertension: A Cross-Sectional Designed Study.高血压患者的生活质量及其与治疗满意度、药物依从性和对医生信任度的关联:一项横断面设计研究
J Cardiovasc Pharmacol Ther. 2018 Nov;23(6):532-542. doi: 10.1177/1074248418784292. Epub 2018 Jun 19.
8
Health-related quality of life of hypertension in China: a systematic review and meta-analysis.中国高血压患者的健康相关生活质量:系统评价和荟萃分析。
J Cardiovasc Med (Hagerstown). 2018 Aug;19(8):430-438. doi: 10.2459/JCM.0000000000000678.
9
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.1990 - 2015年79种行为、环境与职业及代谢风险或风险群组的全球、区域和国家比较风险评估:全球疾病负担研究2015的系统分析
Lancet. 2016 Oct 8;388(10053):1659-1724. doi: 10.1016/S0140-6736(16)31679-8.
10
Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) IV cross-sectional survey in 14 European regions.心血管疾病高危人群的生活方式与风险因素管理。欧洲心脏病学会关于欧洲通过干预进行二级和一级预防以减少事件行动(EUROASPIRE)IV在14个欧洲地区开展的横断面调查的报告。
Eur J Prev Cardiol. 2016 Dec;23(18):2007-2018. doi: 10.1177/2047487316667784. Epub 2016 Sep 27.